What causes eczema in infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Eczema in Infants

Infantile eczema results from a complex interplay between genetic predisposition, skin barrier dysfunction, immune system dysregulation, and environmental triggers—with family history of atopic disease being the strongest predictor. 1

Genetic Factors

Family history is the most significant risk factor for infantile eczema. Children with a mother who has eczema face nearly 3-fold increased risk (OR 2.80), while paternal allergic rhinitis increases risk by approximately 2-fold (OR 1.91). 2 The heritability of eczema is substantial, estimated at 73.59% when considering parental history. 3

  • Filaggrin gene mutations are a key genetic contributor, increasing eczema risk more than 3-fold (OR 3.20). 2 These mutations cause genetically determined skin barrier deficiency. 1
  • Specific genetic variants in CD14-159C/T and IL4Ralpha I75V genes significantly increase susceptibility, particularly when both are present together (OR 3.44). 4

Skin Barrier Dysfunction

The skin barrier defect is central to infantile eczema pathophysiology, occurring through both genetic and environmental mechanisms. 1

  • Barrier disruption allows increased penetration of allergens, irritants, and microbes, triggering inflammatory cascades. 1
  • This creates a self-perpetuating itch-scratch cycle where scratching further damages the barrier, worsening inflammation and pruritus. 1

Immune System Dysregulation

The infant immune system in eczema shows characteristic Th2-dominant inflammation. 1

  • Acute phase: Marked by T helper 2 (Th2) cell activation with elevated IL-4, IL-5, IL-13, and IL-31. 1
  • Chronic phase: Additional Th1 response develops with increased interferon-γ and IL-12. 1
  • Keratinocytes produce thymic stromal lymphopoietin (TSLP), IL-25, and IL-33, which activate type 2 innate lymphoid cells and amplify Th2 responses. 1

Environmental Risk Factors

Perinatal and Birth Factors

  • Prematurity and low birth weight significantly increase eczema risk. 3
  • Shorter birth length is protective—each centimeter increase in birth length reduces risk (OR 0.87 per cm). 2

Early Life Exposures

  • Antibiotic use before age 1 year substantially increases eczema risk. 3
  • Humid living environment during pregnancy and the infant's first year is a significant risk factor. 3
  • Exposure to allergens, fungal elements, tobacco smoke, and air pollutants can trigger or exacerbate disease. 1
  • Maternal stress during pregnancy may contribute to eczema development. 1

Protective Factors

  • Dog ownership in the home reduces eczema risk by approximately 50% (OR 0.44-0.54), particularly when exposure occurs during the first year of life. 4, 2 This protective effect is most pronounced in children carrying the CD14-159C/T CC genotype. 4

Clinical Implications

Understanding these causes is critical because eczema often represents the first step in the "atopic march"—the progression from atopic dermatitis to asthma and allergic rhinitis. 1, 5 Early identification of high-risk infants (those with family history of atopy, filaggrin mutations, or multiple environmental exposures) may enable preventive interventions.

Common Pitfalls

  • Do not assume all cases have identifiable triggers—the multifactorial nature means some infants develop eczema despite minimal environmental exposures. 6
  • Avoid recommending dietary restrictions without professional supervision, as evidence shows little benefit in most cases and risks nutritional deficiency. 6
  • Do not attempt house dust mite eradication as a preventive measure—current evidence does not support this intervention. 6

References

Guideline

Causes and Mechanisms of Infantile Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk analysis of early childhood eczema.

The Journal of allergy and clinical immunology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.